Andrea Erxleben

Find an error

Name:
Organization: National University of Ireland , Ireland
Department: School of Chemistry
Title: Lecture(PhD)
Co-reporter:Marwah Aljohani, Anuradha R. Pallipurath, Patrick McArdle, and Andrea Erxleben
Crystal Growth & Design October 4, 2017 Volume 17(Issue 10) pp:5223-5223
Publication Date(Web):September 1, 2017
DOI:10.1021/acs.cgd.7b00745
Cocrystal formation of chlorothiazide (ctz) was screened with a variety of coformers with carboxyl, amide, hydroxyl, sulfonamide, pyridine, amidine, and amine functional groups. New cocrystals with acetamide (aca), benzamide (bza), propionamide (ppa), caprolactam (cap), carbamazepine (cbz), nicotinamide (nia), isonicotinamide (ina), hexamethylenetetramine (hma), 4,4′-bipyridine (bipy), 1,2-di(4-pyridyl)ethylene (ebipy), 2-hydroxypyridine (hyp), 1,3-di(4-pyridyl)propane (pbipy) and pyrazine (pyr) as well as a benzamidinium (bzamH+) salt were obtained by mechanical grinding and liquid-assisted grinding and identified by powder X-ray diffraction. The structures of ctz-bza, ctz-cbz, ctz-ina, ctz-nia, ctz-hma, ctz-bipy, ctz-ebipy, ctz-pbipy, and (bzamH+)(ctz–) were determined by single-crystal X-ray diffraction. Analysis of the hydrogen bonding motifs showed that in all cocrystal structures except for ctz-bipy, the NHsulfonamide···N(SO2)═C catemer synthon of ctz form I is replaced by ctz-coformer heterosynthons. The dissolution behavior and relationship between dissolution rate, packing index, and lattice energy of the cocrystals is described. To understand why no cocrystals with carboxylic acids formed, a motif search of the Cambridge Structural Database (CSD) was carried out.
Co-reporter:D. Montagner;B. Fresch;K. Browne;V. Gandin;A. Erxleben
Chemical Communications 2017 vol. 53(Issue 1) pp:134-137
Publication Date(Web):2016/12/20
DOI:10.1039/C6CC08100B
A new Cu-based anticancer metallodrug which targets the translocator protein is reported. [CuBr2(TZ6)] elicits a remarkable in vitro cytotoxicity in sensitive and multidrug resistant cell lines and induces a 98% reduction of tumor mass in a murine tumor model. Target binding was studied by experimental and computational methods.
Co-reporter:Awatif Rashed Z. Almotairy, Valentina Gandin, Liam Morrison, Cristina Marzano, Diego Montagner, Andrea Erxleben
Journal of Inorganic Biochemistry 2017 Volume 177(Volume 177) pp:
Publication Date(Web):1 December 2017
DOI:10.1016/j.jinorgbio.2017.09.009
•Five new anticancer platinum(IV) pro-drugs were synthesized.•The complexes are based on carboplatin and a histone deacetylase (HDAC) inhibitor.•The most active complex is up to 10 times more cytotoxic than carboplatin.•The most effective complex decreases cellular basal HDAC activity by ca. 18%.Five new platinum(IV) derivatives of carboplatin each incorporating the histone deacetylase inhibitor 4-phenylbutyrate in axial position were synthesized and characterized by 1H and 195Pt NMR spectroscopy, electrospray ionization mass spectrometry and elemental analysis, namely cis,trans-[Pt(CBDCA)(NH3)2(PBA)(OH)] (1), cis,trans-[Pt(CBDCA)(NH3)2(PBA)2] (2), cis,trans-[Pt(CBDCA)(NH3)2(PBA)(bz)] (3), cis,trans-[Pt(CBDCA)(NH3)2(PBA)(suc)] (4) and cis,trans-[Pt(CBDCA)(NH3)2)(PBA)(ac)] (5) (PBA = 4-phenylbutyrate, CBDCA = 1,1-cyclobutane dicarboxylate, bz = benzoate, suc = succinate and ac = acetate). The reduction behavior in the presence of ascorbic acid was studied by high performance liquid chromatography. The cytotoxicity against a panel of human tumor cell lines, histone deacetylase (HDAC) inhibitory activity, cellular accumulation and the ability to induce apoptosis were evaluated. The most effective complex, compound 3, was found to be up to ten times more effective than carboplatin and to decrease cellular basal HDAC activity by approximately 18% in A431 human cervical cancer cells.The synthesis and cytotoxic activity of five platinum(IV) complexes based on the carboplatin scaffold and the histone deacetylase inhibitor 4-phenylbutyric acid are reported.Download high-res image (117KB)Download full-size image
Co-reporter:Anuradha R. Pallipurath, Francesco Civati, Juraj Sibik, Clare Crowley, J. Axel Zeitler, Patrick McArdle, Andrea Erxleben
International Journal of Pharmaceutics 2017 Volume 528, Issues 1–2(Issue 1) pp:
Publication Date(Web):7 August 2017
DOI:10.1016/j.ijpharm.2017.06.020
Understanding phase transitions in pharmaceutical materials is of vital importance for drug manufacturing, processing and storage. In this paper we have carried out comprehensive high-resolution spectroscopic studies on the polymorphs of the non-steroidal anti-inflammatory drug diflunisal that has four known polymorphs, forms I–IV (FI–FIV), three of which have known crystal structures. Phase transformations during milling, heating, melt-quenching and exposure to high relative humidity were investigated using Raman and terahertz spectroscopy in combination with differential scanning calorimetry and X-ray powder diffraction. The observed phase transformations indicate the stability order FIII > FI > FII, FIV. Furthermore, crystallization experiments from the gas phase and from solution by fast evaporation of different solvents were carried out. Fast evaporation of an ethanolic solution below 70 °C was identified as a reliable and convenient method to obtain the somewhat elusive FII in bulk quantities.
Co-reporter:Naghmeh Kamali, Andrea Erxleben, and Patrick McArdle
Crystal Growth & Design 2016 Volume 16(Issue 5) pp:2492
Publication Date(Web):April 11, 2016
DOI:10.1021/acs.cgd.6b00415
Sublimation of carbamazepine, piracetam, diflunisal, and p-aminobenzoic acid is enhanced by the presence of additives. Temperature reductions and polymorph control have been observed. Sublimation of carbamazepine containing less than 5% by weight of acetamide reduces the sublimation temperature by 20 °C and yields pure form I. In the absence of acetamide, carbamazepine sublimation yields forms I and III. The enhancement mechanism appears to involve more volatile adduct formation. Sublimation of carbamazepine onto polycrystalline powder templates of carbamazepine forms I, II, and III yields pure samples of these forms. Valeric acid is an effective additive in sublimations of diflunisal, piracetam, and p-aminobenzoic acid.
Co-reporter:Anuradha R. Pallipurath, Francesco Civati, Magdalene Eziashi, Elaf Omar, Patrick McArdle, and Andrea Erxleben
Crystal Growth & Design 2016 Volume 16(Issue 11) pp:6468
Publication Date(Web):September 26, 2016
DOI:10.1021/acs.cgd.6b01154
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long needles has been achieved by breaking the stacking effect with the help of coformers. Eight new cocrystals are reported, along with three crystal structures. In all cases, ortho F disorder, often a feature in diflunisal structures was absent due to the presence of CH···F interactions. Co-milling diflunisal with oxalic acid produced 1:1 and 2:1 cocrystals. In contrast, in solution crystallization, oxalic acid played the role of an additive resulting in the crystallization of diflunisal form I rather than form III. To rationalize cocrystal formation, a statistical analysis of the Cambridge Crystallographic Data Centre database for aromatic o-hydroxy carboxylic acids was carried out. All cocrystals of o-hydroxy carboxylic acids with the COOH dimer motif have an electron-withdrawing group on one of the acids. COOH···Nar motifs are formed preferentially over carboxylic homodimers in the presence of an Nar coformer.
Co-reporter:Thaylan Pinheiro Araujo, Valentina Gandin, Paul Kavanagh, Jeremy Phillip Braude, Luca Nodari, Diego Montagner, Andrea Erxleben
Inorganica Chimica Acta 2016 Volume 452() pp:170-175
Publication Date(Web):1 October 2016
DOI:10.1016/j.ica.2016.02.044
•A new bimetallic, bis(triaza)-cyclononane Fe(III) complex has been prepared.•The complex causes oxidative DNA single-strand breaks at low micromolar concentration.•The complex is 2.5 times more cytotoxic against colon LoVo cancer cells than cisplatin.A novel bimetallic Fe(III) complex with the bis(triaza-cyclononane) ligand 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol (bcmp) is reported. [Fe2{bcmp(-H)}(μ-OH)Cl2]Cl2 (2) contains two octahedral Fe(III) centers bound to the two triaza-cyclononane rings of bcmp. The coordination sphere is completed by one chlorine, one bridging phenolate oxygen and one bridging hydroxide group. The complex has been characterized by elemental analysis, Mössbauer spectroscopy, UV–Vis spectroscopy, pH potentiometric titration, ESI mass spectrometry and cyclic voltammetry. The complex hydrolyzes the DNA model bis(2,4-dinitrophenyl) phosphate (BDNPP) with a maximum activity a pH 7. Michaelis–Menten behavior is observed with kcat = 3.56 × 10−4 s−1 and Km = 0.56 mM (pH 7.0, 40 °C). The interaction of 2 with CT DNA was studied by electronic absorption spectroscopy and gel electrophoresis. Notably, the complex relaxes supercoiled pUC19 DNA into the nicked form at low micromolar concentration (10 μM) in the presence of an external reducing agent (ascorbic acid). Finally, the in vitro antiproliferative activity of 2 was assessed on a panel of human cancer cell lines and results revealed that the complex exhibited a significant cytotoxic effects in particular versus colon LoVo cancer cells, wih IC50 value 2.5 times lower than that shown by the reference metallodrug cisplatin (3.54 versus 8.53 μM).The bimetallic Fe(III) complex of 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol relaxes supercoiled pUC19 DNA into the nicked form at low micromolar concentration in the presence of an external reducing agent and exhibits significant cytotoxic effects against colon LoVo cancer cells with an IC50 value 2.5 times lower than that of cisplatin.
Co-reporter:Nicole Walshe, Mairead Crushell, Jolanta Karpinska, Andrea Erxleben, and Patrick McArdle
Crystal Growth & Design 2015 Volume 15(Issue 7) pp:3235
Publication Date(Web):June 9, 2015
DOI:10.1021/acs.cgd.5b00348
The crystal structures and crystal morphology of the mono-semicarbazone of 9,10-phenanthraquinone and nine of its solvates were examined to probe the mechanism of crystal growth of flat molecules. Three of the solvates were isomorphous, did not have stacked structures, and grew as blocks. Six of the solvates had stacked structures and grew as needles. A centroid distance based method for the detection of van der Waals (vdW) contact stacking is described. Nonflat carbamazepine (CBZ) forms I, III, and VI, 4-hydroxy-N-phenylbenzenesulfonamide, and a polymorph of 1,4-diphenyl-2H-cyclopenta[d]pyridazine all exhibited needle growth and have structures which maximize vdW contact stacking in the needle growth direction. The experimentally reported anisotropic dissolution of CBZ form I has been simulated using molecular dynamics. The intermolecular interactions have been analyzed using Gavezzotti’s PIXEL program. Dispersion force interactions between the molecules are most important within the stacks. A crystal growth mechanism driven by the dispersion force rather than hydrogen bonding is suggested for both flat and nonflat molecules.
Co-reporter:Naghmeh Kamali, Marwah Aljohani, Patrick McArdle, and Andrea Erxleben
Crystal Growth & Design 2015 Volume 15(Issue 8) pp:3905
Publication Date(Web):July 14, 2015
DOI:10.1021/acs.cgd.5b00529
Ten benzamidinium salts of carboxylic acids, amides, and sulfonamides have been crystallized from solution. Single-crystal X-ray analyses revealed various hydrogen bonding motifs which are discussed in terms of supramolecular synthons and graph sets. Benzamidinium hydrogen maleate (5a) crystallizes as large needles of up to >3 cm in length. Attempts to influence the crystal habit and size through a change of solvent and the presence of additives yielded a second polymorph (5b). The formation of the benzamidinium salts by mechanochemical reaction was also investigated. Grinding of benzamidine with nicotinic acid, salicylic acid, p-aminobenzoic acid, cyanuric acid, pimelic acid, saccharin, and sulfathiazole with mortar and pestle or using a ball-mill gave compounds identical to those obtained by crystallization from solution. Time-dependent X-ray powder patterns of a stoichiometric benzamidine/cyanuric acid mixture suggested that the mechanochemical salt formation occurred via the amorphous state. Ball-milling of benzamidine with sulfamerazine generated amorphous benzamidinium sulfamerazinate that was stable toward crystallization for at least 2 weeks, when stored at 25% relative humidity.
Co-reporter:Leila Tabrizi, Patrick McArdle, Andrea Erxleben, Hossein Chiniforoshan
European Journal of Medicinal Chemistry 2015 Volume 103() pp:516-529
Publication Date(Web):20 October 2015
DOI:10.1016/j.ejmech.2015.09.018
•Nickel(II) and cobalt(II) complexes of lidocaine were synthesized.•The complexes were characterized using various spectrometric techniques and crystallography.•The complexes can cleave CT DNA.•The cytotoxicity of the complexes against human cell lines is comparable to that of cisplatin.Metal complexes of the type [Ni(LC)2(X)2], 1 and 2, [Co(LC)2(X)2], 3 and 4 (LC: lidocaine, X = dca (dicyanamide), 1 and 3, X = NCS−, 2 and 4) have been synthesized and characterized. The geometries of 1–4 were confirmed by single crystal X-ray crystallography. The complexes are water soluble and stable in aqueous solution. The interaction of 1–4 with calf thymus DNA (CT DNA) and bovine serum albumin (BSA) was investigated using UV–visible and fluorescence spectrophotometric methods. A gel electrophoresis assay demonstrated that the complexes cleave pUC19 plasmid DNA. The in vitro free radical scavenging, antimicrobial activity and cytotoxic potential of all the complexes were examined.Nickel(II) and cobalt(II) complexes of lidocaine were synthesized, characterized, and investigated for their bioactivity.
Co-reporter:Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle
Molecular Pharmaceutics 2015 Volume 12(Issue 10) pp:3735-3748
Publication Date(Web):August 28, 2015
DOI:10.1021/acs.molpharmaceut.5b00504
Understanding the polymorphism exhibited by organic active-pharmaceutical ingredients (APIs), in particular the relationships between crystal structure and the thermodynamics of polymorph stability, is vital for the production of more stable drugs and better therapeutics, and for the economics of the pharmaceutical industry in general. In this article, we report a detailed study of the structure–property relationships among the polymorphs of the model API, Sulfamerazine. Detailed experimental characterization using synchrotron radiation is complemented by computational modeling of the lattice dynamics and mechanical properties, in order to study the origin of differences in millability and to investigate the thermodynamics of the phase equilibria. Good agreement is observed between the simulated phonon spectra and mid-infrared and Raman spectra. The presence of slip planes, which are found to give rise to low-frequency lattice vibrations, explains the higher millability of Form I compared to Form II. Energy/volume curves for the three polymorphs, together with the temperature dependence of the thermodynamic free energy computed from the phonon frequencies, explains why Form II converts to Form I at high temperature, whereas Form III is a rare polymorph that is difficult to isolate. The combined experimental and theoretical approach employed here should be generally applicable to the study of other systems that exhibit polymorphism.
Co-reporter:Diego Montagner, Valentina Gandin, Cristina Marzano, Andrea Erxleben
Journal of Inorganic Biochemistry 2015 Volume 145() pp:101-107
Publication Date(Web):April 2015
DOI:10.1016/j.jinorgbio.2015.01.013
•A bis(triazacyclonane) dicopper complex is reported that cleaves DNA in Capan-1 cells.•The complex shows very promising activity against various pancreatic tumor cell lines.•The complex can activate apoptotic cell death pathways by a mechanism that is p53-dependent.The dinuclear copper(II) complex [Cu2{bcmp(-H)}(μ-OH)](NO3)2·H2O (1, bcmp = 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol) has been synthesized and characterized by electrospray ionization mass spectrometry, potentiometric titration and cyclovoltammetry. The X-ray structure of the analogous perchlorate salt [Cu2{bcmp(-H)}(μ-OH)](ClO4)2·2.5H2O (2) was determined. Cytotoxicity studies showed very promising activity of 1 against various pancreatic tumor cell lines with IC50 values comparable or even lower than those of cisplatin. The Cu complex displayed low toxicity against a human non-tumor cell line (HEK 293) demonstrating selectivity for cancer cells. 1 converts supercoiled pUC19 plasmid DNA into the nicked form at micromolar concentrations in the absence of added reductants. A detailed kinetic study on the hydrolysis of the DNA model bis(2,4-dinitrophenyl) phosphate (BDNPP) has been performed. 1 hydrolyses BDNPP with a second order rate constant of 0.047 M s− 1 at pH 8 and 40 °C. Finally, single cell electrophoresis (comet assay) and fluorescence microscopy analysis showed that 1 interacts with cellular DNA and induces apoptotic cell death of Capan-1 pancreatic cancer cells. Western blotting analysis indicated that the Cu complex activates the p53 dependent pathway of apoptosis.A new dinuclear bis(triazacyclonane) copper complex is reported that represents a “self-activating” metallonuclease with interesting cytotoxic activity against pancreatic cancer cell lines.
Co-reporter:Leila Tabrizi, Patrick McArdle, Andrea Erxleben, Hossein Chiniforoshan
Inorganica Chimica Acta 2015 Volume 438() pp:94-104
Publication Date(Web):1 November 2015
DOI:10.1016/j.ica.2015.09.011
•Two triorganotin(IV) complexes with phenylcyanamide ligands were synthesized and characterized.•The interaction of the triorganotin(IV) complexes with CT-DNA was investigated.•The triorganotin(IV) complexes bind to bovine serum albumin proteins.•The triorganotin(IV) complexes are cytotoxic and have antioxidant properties.This article describes the synthesis and characterization of novel triorganotin(IV) complexes and their potential medicinal applications. Triorganotin(IV) complexes with formulas [(SnMe3)2(μ-bp)(H2O)2], 1, and [(SnMe3)(4-NO2pcyd)], 2, (Me: methyl, bpH2: 4,4′-dicyanamidobiphenyl and 4-NO2pcyd: 4-nitrophenylcyanamide) have been synthesized via a sonochemical process and characterized using multinuclear NMR (1H, 13C and 119Sn), Mössbauer spectroscopy, elemental analysis, scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Compounds 1 and 2 were evaluated for their DNA/protein binding with calf thymus DNA (CT-DNA) and bovine serum albumin (BSA), respectively. The in vitro cytotoxicity of 1 and 2 was examined against A549, Du145, HeLa and MCF-7 cancer cell lines. For 1, a promising growth inhibitory effect against HeLa cells was observed that is slightly higher than that of cisplatin. Moreover, the antimicrobial activity of 1 and 2 against different strains of pathogenic bacteria and fungi were tested. The free radical scavenging ability (OH, NO) of 1 and 2 was assessed.The biological activity of triorganotin(IV) phenylcyanamide complexes prepared by sonochemical synthesis is reported.
Co-reporter:Yun Hu, Katarzyna Gniado, Andrea Erxleben, and Patrick McArdle
Crystal Growth & Design 2014 Volume 14(Issue 2) pp:803-813
Publication Date(Web):December 20, 2013
DOI:10.1021/cg401673z
The anhydrous solvent-free mechanochemical reaction of sulfathiazole, STZ, polymorphs I, III, and V with 10 carboxylic acids was monitored by powder X-ray diffraction (PXRD), attenuated total reflectance infrared (ATR-IR), and near-infrared (NIR) spectroscopy. A 1:1 cocrystal was observed with glutaric acid and the strongest acid, oxalic acid, gave a 1:1 salt. A principal components analysis of the glutaric acid NIR data showed that forms I and V proceeded to the cocrystal, but that form III transformed to form IV before cocrystal formation. The oxalic acid salt was formed via complete amorphization. The crystal structures of the cocrystal and the salt were determined. Sulfathiazole comilled with l-tartaric and citric acids gave coamorphous systems that were stable at 10% RH for up to 28 days. Comilling sulfathiazole with dl-malic acid gave mixtures of form V and the amorphous form.
Co-reporter:Diego Montagner;Valentina Gin;Cristina Marzano
European Journal of Inorganic Chemistry 2014 Volume 2014( Issue 25) pp:4084-4092
Publication Date(Web):
DOI:10.1002/ejic.201402319

Abstract

The dinuclear zinc complex [Zn2{bcmp(-H)}(μ-Cl)](ClO4)2·H2O {bcmp = 2,6-bis(1,4,7-triazacyclonon-1-ylmethyl)-4-methylphenol} has been synthesized and structurally characterized. The DNA binding affinity was assessed by ethidium bromide fluorescence quenching experiments. The complex relaxes supercoiled pUC19 DNA into the nicked form at low micromolar concentration. Mechanistic studies were carried out using the DNA and RNA models bis(2,4-dinitrophenyl) phosphate (BDNPP) and 2-hydroxypropyl p-nitrophenyl phosphate (HPNP). A detailed kinetic analysis suggested that the bridging OH group of the solution species [Zn2{bcmp(-H)}(μ-OH)]2+ acts as the nucleophile in the hydrolysis of BDNPP, while in the case of HPNP, the bridging OH group acts as a general base and seems to shift to a terminal position upon substrate coordination. Finally, the cytotoxicity profile of the dinuclear zinc(II) complex was assessed. The complex showed promising in vitro antitumour activity against pancreatic and lung cancers cell lines.

Co-reporter:Diego Montagner;Valentina Gin;Cristina Marzano
European Journal of Inorganic Chemistry 2014 Volume 2014( Issue 25) pp:
Publication Date(Web):
DOI:10.1002/ejic.201402698

Abstract

Invited for the cover of this issue are researchers from the National University of Ireland, Galway, and the University of Padua, Italy. The cover image shows the X-ray structure of the dinuclear bis(1,4,7-triazacyclononane) zinc complex synthesized in this work. The complex converts supercoiled plasmid DNA into the nicked form at low micromolar concentration and shows promising in vitro antitumor activity against pancreatic and lung cancer cell lines.

Co-reporter:Diego Montagner;Valentina Gin;Cristina Marzano
European Journal of Inorganic Chemistry 2014 Volume 2014( Issue 25) pp:
Publication Date(Web):
DOI:10.1002/ejic.201490123
Co-reporter:Pól Macfhionnghaile;Yun Hu;Katarzyna Gniado;Sinead Curran;Patrick Mcardle
Journal of Pharmaceutical Sciences 2014 Volume 103( Issue 6) pp:1766-1778
Publication Date(Web):
DOI:10.1002/jps.23978

The effects of ball-milling and cryomilling on sulfamerazine forms I and II (SMZ FI, FII) were investigated using X-ray powder diffraction, infrared and near-infrared (NIR) spectroscopy. Cryomilling resulted in a complete amorphization of both polymorphs. Milling at room temperature gave mixtures of amorphous SMZ (FA) and FII. Calibration models were developed for the quantitative analysis of binary (FI/FII, FI/FA, and FII/FA) and ternary (FI/FII/FA) mixtures using NIR spectroscopy combined with partial least-squares (PLS) regression. The PLS models for binary (0%–100%), ternary (0%–100%), and low-level (0%–10%) binary mixtures had root-mean-square errors of prediction of ≤1.8%, ≤5.1%, and ≤0.80%, respectively. The calibration models were used to obtain a detailed quantitative picture of solid-state transformations during milling and any subsequent recrystallizations. FA prepared by cryomilling FI for less than 60 min recrystallized to mixtures of FI and FII, whereas samples milled for more than 60 min crystallized to pure FII. The effect of comilling SMZ with stoichiometric amounts of additives was investigated. SMZ formed amorphous materials with oxalic, dl-tartaric, and citric acids that were more stable toward recrystallization than FA. Amorphous SMZ/oxalic acid was found to recrystallize to a 2:1 cocrystal during storage. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci

Co-reporter:Yun Hu, Andrea Erxleben, B. Kieran Hodnett, Boyan Li, Patrick McArdle, Åke C. Rasmuson, and Alan G. Ryder
Crystal Growth & Design 2013 Volume 13(Issue 8) pp:3404
Publication Date(Web):July 11, 2013
DOI:10.1021/cg4002779
The effect of milling on the transitions of sulfathiazole polymorphs in the absence and presence of solvent and excipients was monitored by X-ray powder diffraction (XRPD), attenuated total reflectance infrared (ATR-IR), and near-infrared (NIR) spectroscopy. Sulfathiazole forms FII–FV undergo a transformation toward the metastable FI, which involves an intermediate amorphous stage upon milling at ambient temperature. Milling the commercial form (FC) with catalytic amounts of solvent converts it to pure FIV or to mixtures of FI and FIV depending on the solvent used. Pure FIV can be easily prepared from FC by this method. The physical stability of nonmechanically activated pure sulfathiazole forms in the presence of different levels of relative humidity (RH) was also investigated. At low RH, all sulfathiazole forms are kinetically stable, but at RH levels above 70% FII, FC and FIV remain stable, while FI and FV transform to mixtures of FII and FIV without any apparent change in the external form of the crystals. Comilling FC with a range of excipients gave results that depended on the excipient used, and comilling with cellulose gave samples that had an amorphous content that was stable at 10% RH for at least nine months at ambient temperature.
Co-reporter:Yun Hu;Pól Macfhionnghaile;Vincent Caron;Lidia Tajber;Anne Marie Healy;Patrick McArdle
Journal of Pharmaceutical Sciences 2013 Volume 102( Issue 1) pp:93-103
Publication Date(Web):
DOI:10.1002/jps.23338

Abstract

The formation and physical stability of amorphous sulfathiazole obtained from polymorphic forms I and III by cryomilling was investigated by X-ray powder diffraction (XRPD) and near-infrared (NIR) spectroscopy. Principal component analysis was applied to the NIR data to monitor the generation of crystalline disorder with milling time and to study subsequent recrystallization under different storage conditions. Complete conversion into the amorphous phase was observed for both forms after 45 (form I) and 150 min (form III) milling time. Upon storage under vacuum over silica gel for 14 days at 4°C, amorphous samples remained amorphous. However, under the same conditions at ambient temperature, recrystallization occurred. Amorphous samples obtained from form I had crystallized back to the original polymorph, whereas those prepared from form III had partially crystallized to mixtures of polymorphs. Amorphous samples stored at ambient temperature and humidity absorbed moisture, which facilitated crystallization to a mixture of polymorphs in both cases. Quantitative analyses of amorphous content in binary mixtures with forms I and III were carried out by XRPD and NIR spectroscopy combined with partial least squares regression. The calibration models had root mean square error of prediction values of <2.0% and were applied to quantify the extent of crystalline disorder during cryomilling. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:93–103, 2013

Co-reporter:Fergal Coleman, Andrea Erxleben
Polyhedron 2012 Volume 48(Issue 1) pp:104-109
Publication Date(Web):14 November 2012
DOI:10.1016/j.poly.2012.09.015
Three zirconium(IV) complexes (1–3) with mono- and dinucleating tripodal ligands are reported that promote the hydrolysis of the phosphate monoesters p-nitrophenyl phosphate (NPP) and phenyl phosphate (PP) in neutral solution. At pH 7 up to 104- and 106-fold rate accelerations of the hydrolysis of NPP and PP are observed. A detailed kinetic study has been carried out for NPP. The complexes show Michaelis–Menten behavior, kcat and 1/Km values at pH 7.0, 25 °C are 2.7 × 10−5 s−1 and 806 M−1 (1), 1.1 × 10−4 s−1 and 556 M−1 (2) and 1.1 × 10−4 s−1 and 565 M−1 (3). Entropies of activation of −92.0 J K−1 mol−1 (1), −75.6 J K−1 mol−1 (2) and −98.6 J K−1 mol−1 (3) are consistent with an associative mechanism.Graphical abstractMixtures of the mononucleating ligand L1 or of the related dinucleating ligands L2 and L3 with an excess of Zr4+ give homogeneous solutions in the pH range 6–12. The Zr complexes present in aqueous solutions promote the hydrolysis of the phosphate monoesters p-nitrophenyl phosphate and phenyl phosphate at neutral pH.Highlights► Mono- and dinucleating ligands forming homogenous ZrIV solutions between pH 6 and 12. ► Rapid hydrolysis of phenyl phosphate by a dinuclear ZrIV complex at pH 7. ► Kinetic study of phosphomonoester hydrolysis by mono- and dinuclear ZrIV complexes.
Co-reporter:Charlene McHugh and Andrea Erxleben
Crystal Growth & Design 2011 Volume 11(Issue 11) pp:5096-5104
Publication Date(Web):September 13, 2011
DOI:10.1021/cg201007m
Co-crystal and salt formation of the kinetin analogue N6-benzyladenine with the pharmaceutically acceptable co-crystal and salt formers maleic acid, oxalic acid, glutaric acid, succinic acid, benzoic acid, and fumaric acid has been studied by solid-state and solvent-drop grinding in combination with X-ray powder diffraction. In all cases, salt or co-crystal formation was observed. Single crystals of (bzadeH+)(mal–) (1) and (bzadeH+)2(ox2–) (2) were obtained by solution crystallization, and their X-ray structures are reported along with that of (adeH+)2(mal–)2·ade·2H2O (3) (bzadeH+ = N6-benzyladeninium, adeH+ = adeninium, ade = adenine, mal– = hydrogen maleate, ox2– = oxalate). The hydrogen-bonding motifs in 1–3 are discussed. The salts contain a robust bzadeH+-carboxylate or ade-carboxylate R22(9) heterosynthon involving the protonated Hoogsteen sites (N6—H, N7—H) of bzadeH+ and ade. Molecular recognition between the protonated Hoogsteen site and the carboxylate group stabilizes the unusual 7H,9H tautomer of bzadeH+ in 2 and the noncanonical 7H-adenine tautomer in 3.
Co-reporter:Fergal Coleman ; Michael J. Hynes
Inorganic Chemistry 2010 Volume 49(Issue 14) pp:6725-6733
Publication Date(Web):June 21, 2010
DOI:10.1021/ic100722w
The effects of a series of GaIII complexes with tripodal ligands on the hydrolysis rate of the activated phosphate diester bis(2,4-dinitrophenyl)phosphate (BDNPP) have been investigated. In particular, the influence of the nature of the ligand donor sites on the reactivity of GaIII which represents a mimic of the FeIII ion in purple acid phosphatase has been evaluated. It has been shown that replacing neutral nitrogen donor atoms and carboxylate groups by phenolate groups enhanced the reactivity of the Ga complexes. Bell-shaped pH-rate profiles and the measured solvent deuterium isotope effects are indicative of a mechanism that involves nucleophilic attack on the coordinated substrate by Ga−OH. The trend in reactivity found for the different Ga complexes reveals that of the two effects of the metal, Lewis acid activation of the substrate and nucleophile activation, the latter one is more important in determining the intrinsic reactivity of the metal catalyst. The relevance of the present findings for the modulation of the activity of the MIII ion in purple acid phosphatase whose active site contains a phenolate (tyrosine side chain) is discussed.
Co-reporter:Andrea Erxleben, James Claffey, Matthias Tacke
Journal of Inorganic Biochemistry 2010 Volume 104(Issue 4) pp:390-396
Publication Date(Web):April 2010
DOI:10.1016/j.jinorgbio.2009.11.010
The interaction of the antitumoural metallocene dihalides, titanocene dichloride (Cp2TiCl2) and Titanocene Y (bis-[(p-methoxybenzyl)cyclopentadienyl]titanium(IV) chloride), with bis(4-nitrophenyl) phosphate (BNPP), which is a widely used model for the phosphate diester linkages in DNA, has been studied. Cp2TiCl2 has been shown to promote the cleavage of the phosphate diester in weakly acidic solution. At pH 4, 37 °C, a 106-fold rate acceleration over the uncatalysed reaction was observed under pseudo-first-order conditions, when freshly prepared solutions of Cp2TiCl2 were applied. The activity of aged solutions dropped significantly due to the formation of insoluble precipitates of hydrolysed Ti species. The precipitates isolated from aged solutions were shown to act as moderately active, heterogeneous catalysts for BNPP cleavage. By contrast, no hydrolysis of the phosphate diester could be observed in the presence of Titanocene Y. Implications for the mode of action of the apoptosis-inducing metallocene dihalides are discussed.
Co-reporter:Andrea Erxleben
Inorganica Chimica Acta 2009 Volume 362(Issue 3) pp:839-844
Publication Date(Web):20 February 2009
DOI:10.1016/j.ica.2008.02.016
The coordination behaviour of Cu2+ towards 4-bromo-2-[(2-diethylaminoethyl)ethyl-aminomethyl]-6-formylphenol (HL) having phenolate, amine and aldehyde donor sites has been studied. In aqueous, weakly acidic solution Cu2+ coordinates to the phenolate and aldehyde oxygen giving rise to the complexes [Cu(H2L)2X2]X2 (X=NO3− (1a) and CIO4− (1b)), while in alkaline solution a complex of composition [CuL2] (2) is formed. In methanol, the aldehyde groups in 1 and 2 suffer nucleophilic attack from the solvent resulting in the formation of the hemiacetal form of the ligand and in the isolation of [Cu(L′)]2 · 2CH3OH (3). X-ray structures of 1a, 1b and 3 are reported, the latter featuring a rare example of a coordinated methyl-hemiacetal.In aqueous, weakly acidic solution Cu2+ coordinates to the phenolate and aldehyde oxygen of HL. In methanol, HL is converted into the hemiacetal and the corresponding Cu complex providing a rare example of a coordinated methyl-hemiacetal has been structurally characterized.
Co-reporter:Pól Macfhionnghaile, Yun Hu, Katarzyna Gniado, Sinead Curran, ... Andrea Erxleben
Journal of Pharmaceutical Sciences (June 2014) Volume 103(Issue 6) pp:1766-1778
Publication Date(Web):1 June 2014
DOI:10.1002/jps.23978
The effects of ball-milling and cryomilling on sulfamerazine forms I and II (SMZ FI, FII) were investigated using X-ray powder diffraction, infrared and near-infrared (NIR) spectroscopy. Cryomilling resulted in a complete amorphization of both polymorphs. Milling at room temperature gave mixtures of amorphous SMZ (FA) and FII. Calibration models were developed for the quantitative analysis of binary (FI/FII, FI/FA, and FII/FA) and ternary (FI/FII/FA) mixtures using NIR spectroscopy combined with partial least-squares (PLS) regression. The PLS models for binary (0%–100%), ternary (0%–100%), and low-level (0%–10%) binary mixtures had root-mean-square errors of prediction of ≤1.8%, ≤5.1%, and ≤0.80%, respectively. The calibration models were used to obtain a detailed quantitative picture of solid-state transformations during milling and any subsequent recrystallizations. FA prepared by cryomilling FI for less than 60 min recrystallized to mixtures of FI and FII, whereas samples milled for more than 60 min crystallized to pure FII. The effect of comilling SMZ with stoichiometric amounts of additives was investigated. SMZ formed amorphous materials with oxalic, dl-tartaric, and citric acids that were more stable toward recrystallization than FA. Amorphous SMZ/oxalic acid was found to recrystallize to a 2:1 cocrystal during storage. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:1766–1778, 2014
Co-reporter:Yun Hu, Pól Macfhionnghaile, Vincent Caron, Lidia Tajber, ... Patrick McArdle
Journal of Pharmaceutical Sciences (January 2013) Volume 102(Issue 1) pp:93-103
Publication Date(Web):1 January 2013
DOI:10.1002/jps.23338
The formation and physical stability of amorphous sulfathiazole obtained from polymorphic forms I and III by cryomilling was investigated by X‐ray powder diffraction (XRPD) and near‐infrared (NIR) spectroscopy. Principal component analysis was applied to the NIR data to monitor the generation of crystalline disorder with milling time and to study subsequent recrystallization under different storage conditions. Complete conversion into the amorphous phase was observed for both forms after 45 (form I) and 150 min (form III) milling time. Upon storage under vacuum over silica gel for 14 days at 4°C, amorphous samples remained amorphous. However, under the same conditions at ambient temperature, recrystallization occurred. Amorphous samples obtained from form I had crystallized back to the original polymorph, whereas those prepared from form III had partially crystallized to mixtures of polymorphs. Amorphous samples stored at ambient temperature and humidity absorbed moisture, which facilitated crystallization to a mixture of polymorphs in both cases. Quantitative analyses of amorphous content in binary mixtures with forms I and III were carried out by XRPD and NIR spectroscopy combined with partial least squares regression. The calibration models had root mean square error of prediction values of <2.0% and were applied to quantify the extent of crystalline disorder during cryomilling.
Co-reporter:Katarzyna Gniado, Korbinian Löbmann, Thomas Rades, Andrea Erxleben
International Journal of Pharmaceutics (17 May 2016) Volume 504(Issues 1–2) pp:20-26
Publication Date(Web):17 May 2016
DOI:10.1016/j.ijpharm.2016.03.023
A comprehensive study on the dissolution properties of three co-amorphous sulfamerazine/excipient systems, namely sulfamerazine/deoxycholic acid, sulfamerazine/citric acid and sulfamerazine/sodium taurocholate (SMZ/DA, SMZ/CA and SMZ/NaTC; 1:1 molar ratio), is reported. While all three co-formers stabilize the amorphous state during storage, only co-amorphization with NaTC provides a dissolution advantage over crystalline SMZ and the reasons for this were analyzed. In the case of SMZ/DA extensive gelation of DA protects the amorphous phase from crystallization upon contact with buffer, but at the same time prevents the release of SMZ into solution. Disk dissolution studies showed an improved dissolution behavior of SMZ/CA compared to crystalline SMZ. However, enhanced dissolution properties were not seen in powder dissolution testing due to poor dispersibility. Co-amorphization of SMZ and NaTC resulted in a significant increase in dissolution rate, both in powder and disk dissolution studies.Download high-res image (105KB)Download full-size image
Co-reporter:D. Montagner, B. Fresch, K. Browne, V. Gandin and A. Erxleben
Chemical Communications 2017 - vol. 53(Issue 1) pp:NaN137-137
Publication Date(Web):2016/12/01
DOI:10.1039/C6CC08100B
A new Cu-based anticancer metallodrug which targets the translocator protein is reported. [CuBr2(TZ6)] elicits a remarkable in vitro cytotoxicity in sensitive and multidrug resistant cell lines and induces a 98% reduction of tumor mass in a murine tumor model. Target binding was studied by experimental and computational methods.
Glycine, N-(carboxymethyl)-N-[(2-hydroxy-5-methoxyphenyl)methyl]-
2H-Cyclopenta[d]pyridazine, 1,4-diphenyl-
1,3-bis(methylsulfanyl)urea
Propargyl alcohol propoxylate
Phenol, 2,4-dinitro-, 1,1'-(hydrogen phosphate)
2,2',2'',2'''-[(2-hydroxy-5-methylbenzene-1,3-diyl)bis(methanediylnitrilo)]tetraacetic acid
Benzenesulfonamide, 4-amino-N-(3-methylphenyl)-
Glycine, N-(carboxymethyl)-N-(2-pyridinylmethyl)-
Glycine, N-(2-aminoethyl)-N-(carboxymethyl)-
1,4,7-Tritosyl-1,4,7-triazonane